These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14196785)

  • 1. TREATMENT OF MUSCULAR DYSTROPHY WITH A NUCLEOTIDES- NUCLEOSIDES COMBINATION.
    GUEST KE; MCLAY WD
    Br J Clin Pract; 1964 Jul; 18():395-400. PubMed ID: 14196785
    [No Abstract]   [Full Text] [Related]  

  • 2. TREATMENT OF MUSCULAR DYSTROPHY.
    WALTON JN
    Dev Med Child Neurol; 1964 Apr; 6():194-5. PubMed ID: 14141744
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE BEHAVIOR OF SERUM ALDOLASE AND TRANSAMINASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER ANABOLIC AND RE-METABOLIZING THERAPY].
    BUSCAINO GA; SEPE O
    Acta Neurol (Napoli); 1964; 19():523-46. PubMed ID: 14208396
    [No Abstract]   [Full Text] [Related]  

  • 4. LAEVADOSIN IN TREATMENT OF DUCHENNE TYPE OF MUSCULAR DYSTROPHY: PRELIMINARY RESULTS OF A DOUBLE-BLIND CONTROLLED TRIAL.
    PEARCE JM; GUBBAY SS; HARDY J; PENNINGTON RJ; NEWELL DJ; WALTON JN
    Br Med J; 1964 Oct; 2(5414):915-7. PubMed ID: 14185658
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 6. LAEVADOSIN IN MUSCULAR DYSTROPHY.
    JACOBS J
    Br Med J; 1965 Sep; 2(5463):704. PubMed ID: 14337743
    [No Abstract]   [Full Text] [Related]  

  • 7. ANABOLIC STEROIDS AND DIGITOXIN IN THE TREATMENT OF PROGRESSIVE MUSCULAR DYSTROPHY.
    HEYCK H; LAUDAHN G; LUEDERS CJ; MUELLER-STEPHANN H; SCHMIDT-PETER P
    Acta Paediatr Scand; 1965 May; 54():205-17. PubMed ID: 14313408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 9. LAEVADOSIN FOR MUSCULAR DYSTROPHY.
    THOMSON WH
    Br Med J; 1964 Oct; 2(5417):1135-6. PubMed ID: 14198741
    [No Abstract]   [Full Text] [Related]  

  • 10. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H; Schenk S
    Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDY OF SIDEREMIA IN SUBJECTS WITH PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER RE-METABOLIZING THERAPY].
    BUSCAINO GA; SPADETTA V
    Acta Neurol (Napoli); 1964; 19():509-22. PubMed ID: 14208395
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the behavior of some serum enzymatic activities in subjects with progressive muscular dystrophy treated with nucleotide and nucleoside substances. II. Malate dehydrogenase, glutamic oxalacetic transaminase and glutamic-pyruvic transaminase activity].
    Canani MB; Rea F; Capasso DA
    Boll Soc Ital Biol Sper; 1965 Aug; 41(16):901-4. PubMed ID: 5880029
    [No Abstract]   [Full Text] [Related]  

  • 14. [INFLUENCE OF INOSINIC ACID, ALONE OR COMBINED WITH OROTIC ACID, ON THE FREE NUCLEOTIDES IN THE RAT LIVER DURING CARBON TETRACHLORIDE POISONING].
    CARTIER P; LEROUX JP
    C R Seances Soc Biol Fil; 1964; 158():1837-41. PubMed ID: 14262518
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 16. MUSCULAR DYSTROPHY. XI. TRIALS OF 1-METHYL-DELTA-1-ANDROSTENOLONE AND DIGITOXIN.
    DANOWSKI TS; SABEH G; VESTER JW; SARVER ME; SUNDER JH
    Arch Intern Med; 1965 Mar; 115():294-301. PubMed ID: 14252051
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of muscular dystrophy with "Laevadosin".
    Lip P; Flanagan J; Murray P
    Med J Aust; 1969 Jun; 1(26):1386. PubMed ID: 5797171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects and therapy of muscular dystrophies].
    Beckmann R
    Internist (Berl); 1972 Mar; 13(3):108-17. PubMed ID: 4553893
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific activities of acid-soluble nucleotides in hind-leg muscles of mice with dystrophia muscularis.
    ZYMARIS MC; SAIFER A; VOLK BW
    Nature; 1960 Oct; 188():323-4. PubMed ID: 13789062
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of progressive muscular dystrophy].
    Beckmann R
    Med Klin; 1971 Aug; 66(32):1099. PubMed ID: 5562103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.